Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention updated requirements for health care providers participating in the COVID-19 Vaccination Program to clarify that participants may not sell or divert COVID-19 vaccine or ancillary materials purchased for the program; reproduce the program鈥檚 COVID-19鈥
The United States Supreme Court rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did not have 鈥渟tanding,鈥 or the legal right to challenge the portions of the ACA they alleged were unconstitutional.
On this AHA Advancing Health podcast, Leon Caldwell, AHA鈥檚 senior director of health equity strategies and innovation, talks with Keith Ellison, program director of the Urban League of Philadelphia Entrepreneurship Center, about how the COVID-19 pandemic highlighted the pivotal role local鈥
A National Institutes of Health-led review of more than 24,000 stored blood samples suggests that the coronavirus that causes COVID-19 was present in the U.S. as far back as December 2019.
The Food and Drug Administration authorized for emergency use one more batch of drug substance manufactured for the Janssen (Johnson & Johnson) COVID-19 vaccine at an Emergent BioSolutions facility in Baltimore.
Rhode Island health care providers may no longer order the monoclonal antibodies bamlanivimab and etesevimab until further notice due to rising prevalence of the SARS-CoV-2 P.1 and B.1.351 variants, which are not susceptible to the combination therapy, the Department of Health and Human Services鈥欌
The Medicare Payment Advisory Commission issued its June report to Congress on refinements to Medicare payment systems and issues affecting the Medicare program, which includes recommendations approved by the commission in April.
Moderna Inc. announced an agreement with the U.S. government for the purchase of an additional 200 million doses of Moderna鈥檚 COVID-19 vaccine, along with an option to purchase other COVID-19 vaccine candidates in the biotech company鈥檚 development pipeline.
As requested by the AHA, the Centers for Medicare & Medicaid Services said it will continue to remain flexible in its approach to surveys if a hospital experiences a COVID-19 surge.
In this AHA blog Priya Bathija, vice president of strategic initiatives, and Elisa Arespacochaga, vice president of clinical affairs and workforce, share five ways to improve collaborations between administrative and clinical leaders when designing and implementing value-based strategies.